Medicines With The Active Ingredient Infliximab (Atc: L04Ab02 - In The Dosage Form Injection Solution)

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 118311643

  Document Type - Tender Notices

Description - Description: The subject of this publication is the conclusion of non-exclusive discount contracts in accordance with Section 130a (8) SGB V for finished medicinal products with the active ingredient infliximab (ATC: L04AB02-in the daring form inject ion solution) as part of a so-called "open-house model". Under the specification of uniform contractual conditions and uniform access procedures, all suitable and interested pharmaceutical companies or communities of pharmaceutical companies is offered to the conclusion or accession to a discount contract in accordance with Section 130a (8) SGB V for the aforementioned active ingredients or medicines. Interested pharmaceutical companies can reque

Gt Ref Id - 118311643

Deadline - Aug 31, 2027